Objective: to explore the possibility of plasma DNA in the use of fluorescent quantitative analysis of chimerism after hematopoietic stem cell transplantation.
目的：探讨血浆DNA在造血干细胞移植术后嵌合体荧光定量分析中应用的可行性。
Conclusion The plasma DNA level may have a potential use in early diagnosis and serve as a predict marker for metastasis potential and prognosis of ovarian cancer.
结论：血浆DNA水平有可能成为辅助早期诊断卵巢恶性肿瘤、判断肿瘤侵袭转移情况和预测预后的指标之一。
Objective To detect the promoter methylation status of SFRP1 gene in tissue and plasma DNA of non-small cell lung cancer(NSCLC) patients and evaluate its correlation with clinicopathological features.
目的检测SFRP1基因在非小细胞肺癌（NSCLC）组织和血浆中的甲基化状态，分析其临床意义。
I have found these signals coming from bacterial DNA in the plasma of many patients with autism, and also in most, if not all, patients with Alzheimer, Parkinson's disease, and multiple sclerosis.
M大爷：我在很多孤独症病人，绝大多数的老年痴呆病人，帕金森病人和动脉硬化病人的血浆中发现这些来自细菌的信号。
Foetal DNA floats in mother's plasma.
胎儿dna潜藏于母亲的血浆中。
We will first show that we can detect bacterial DNA in the plasma of autistic children and not in a healthy control group.
我们要先展示，我们可以在有孤独症的患病儿童组的血液里可以检测到细菌的DNA，但是在对照的健康组儿童血液中却检测不到；
The correlations only between alanine aminotransferase and the loads of CMV DNA in plasma and leukocytes are significant (P<0.0001), respectively.
血浆及白细胞中CMV-DNA载量均只与丙氨酸转移酶的相关性有统计学意义（P＜0.0001）；
Objective to establish a reliable and effective method for detecting fetal DNA in maternal plasma and to explore its value in non-invasive prenatal diagnosis.
目的建立可靠有效的检测孕妇血浆胎儿dna的方法，探讨其在非创伤性产前诊断中的价值。
Quantitative analysis of fetal cell-free DNA in maternal plasma is of great value in the non-invasive prenatal diagnosis.
提示母体血浆中游离的胎儿dna的定量分析在无创性产前诊断中有重要价值。
Objective To study the fetal DNA in maternal plasma using multiplex PCR amplification of the short tandem repent (STR) systems.
目的采用短串联重复序列（STR）多态位点的复合扩增方法，研究孕妇血浆中胎儿DNA基因型。
Many studies show that 4-oxo-dihydroquinolines have good oral bioavailability and plasma clearance, and they suppress both the DNA polymerase of HSV and virus replication in the cells.
多项研究表明，4 -氧代二氢喹啉类有良好的口服利用率及中等程度的血浆清除率，不仅对核苷酸聚合酶产生抑制，还可以抑制细胞内的病毒复制。
Objective:A mean concentration was shown by quantitative analysis of fetal cell-free DNA in maternal plasma.
提示母体血浆中游离的胎儿DNA 的定量分析在无创性产前诊断中有重要价值。
Objective: To explore the clinic significance of using fetal DNA in maternal plasma for prenatal diagnosis of fetal ABO blood types.
目的：探讨利用孕妇血浆中胎儿dna检测胎儿abo血型的临床意义。
Objective:To establish the new technology for detection of fetal cell-free DNA in maternal plasma at early pregnant stage.
目的：建立一种检测早孕妇女血浆中胎儿游离DNA的新方法。
ConclusionFetal DNA in maternal plasma can be detected in different gestational stages. The detection rates of fetal DNA in maternal plasma increase with the week of gestation.
结论在不同的妊娠阶段都可检测到孕妇血浆中的胎儿dna，胎儿dna检出率随孕周的增加增高。
Objectives: To establish the technology for extracting cell-free fetal DNA in maternal plasma, comparing detection rate of fetal component marker SRY gene and RASSF1A gene.
工作目的：建立母血浆中胎儿游离dna分离提取的技术，利用SRY基因和RASSF1A基因检测胎儿游离dna，并比较它们的检出率。
Results For 18 nasopharyngeal carcinoma patients, positive rates of EB virus DNA in plasma and leucocytes were 61%(11/18);
结果18例鼻咽癌患者外周血血浆和白细胞检测EB病毒DNA的阳性率相同，均为61%（11/18）；
Objective To investigate the value of plasma level determination of EB virus (EBV) DNA for diagnosis making and prognosis estimating among cases with nasopharyngeal carcinoma (NPC).
目的探讨血浆EB病毒DNA定量检测对鼻咽癌的诊断和预后评估价值。
Plasma Epstein-Barr virus DNA (EBV DNA) is a sensitive and specific molecular marker, which can reflect stage, response to treatment and prognosis of NPC.
血浆EB病毒+DNA (EBV DNA)浓度是一项能反映鼻咽癌分期、治疗反应、预后的灵敏、特异的分子生物学指标。
Parental genetic distances were evaluated by plasma protein(enzyme) polymorphisms and DNA molecular level. Their relationship with gene heterozygosities and heterosis of various traits were analyzed.
从猪蛋白质（酶）多态性和DNA分子水平上估测出亲本种群间的遗传距离，探讨它们与基因杂合度及经济性状杂优率之间的关系。
The discovery of free fetal DNA in maternal plasma in 1997 opened up new possibilities for non-invasive prenatal diagnosis.
1997年胎儿游离dna的发现为无创性产前诊断开辟了新的途径。
Conclusions: Establish effective and steady technology for separating and extracting cell-free fetal DNA in maternal plasma.
结论：建立了有效和稳定地分离提取母血浆中胎儿游离dna的技术。
Conclusions: Establish effective and steady technology for separating and extracting cell-free fetal DNA in maternal plasma.
结论：建立了有效和稳定地分离提取母血浆中胎儿游离dna的技术。
应用推荐